Developing neuroscience-based treatments for alcohol addiction: A matter of choice?


Journal

Translational psychiatry
ISSN: 2158-3188
Titre abrégé: Transl Psychiatry
Pays: United States
ID NLM: 101562664

Informations de publication

Date de publication:
08 10 2019
Historique:
received: 15 03 2019
accepted: 08 08 2019
revised: 05 07 2019
entrez: 10 10 2019
pubmed: 9 10 2019
medline: 17 7 2020
Statut: epublish

Résumé

Excessive alcohol use is the cause of an ongoing public health crisis, and accounts for ~5% of global disease burden. A minority of people with recreational alcohol use develop alcohol addiction (hereafter equated with "alcohol dependence" or simply "alcoholism"), a condition characterized by a systematically biased choice preference for alcohol at the expense of healthy rewards, and continued use despite adverse consequences ("compulsivity"). Alcoholism is arguably the most pressing area of unmet medical needs in psychiatry, with only a small fraction of patients receiving effective, evidence-based treatments. Medications currently approved for the treatment of alcoholism have small effect sizes, and their clinical uptake is negligible. No mechanistically new medications have been approved since 2004, and promising preclinical results have failed to translate into novel treatments. This has contributed to a reemerging debate whether and to what extent alcohol addiction represents a medical condition, or reflects maladaptive choices without an underlying brain pathology. Here, we review this landscape, and discuss the challenges, lessons learned, and opportunities to retool drug development in this important therapeutic area.

Identifiants

pubmed: 31594920
doi: 10.1038/s41398-019-0591-6
pii: 10.1038/s41398-019-0591-6
pmc: PMC6783461
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

255

Références

Addict Biol. 2020 Jan;25(1):e12717
pubmed: 30748046
Neuropsychopharmacology. 2017 Aug;42(9):1789-1799
pubmed: 28294133
Neuropsychopharmacology. 2018 Mar;43(4):891-899
pubmed: 29154368
Addiction. 2009 Feb;104(2):224-33
pubmed: 19149817
Alcohol Clin Exp Res. 2015 Nov;39(11):2189-99
pubmed: 26414337
JAMA Psychiatry. 2017 Mar 1;74(3):224-232
pubmed: 28146250
J Neurosci. 2015 Apr 15;35(15):6153-64
pubmed: 25878287
Neuropsychopharmacology. 2016 Nov;41(12):2818-2829
pubmed: 27109623
Sci Transl Med. 2012 Oct 10;4(155):155cm11
pubmed: 23052291
Lancet. 2003 May 17;361(9370):1677-85
pubmed: 12767733
Neuropsychopharmacology. 2018 Apr;43(5):1032-1040
pubmed: 28901327
Addict Biol. 2013 Jan;18(1):121-33
pubmed: 22574861
Science. 2018 Jun 22;360(6395):1321-1326
pubmed: 29930131
Annu Rev Psychol. 2004;55:431-61
pubmed: 14744222
Clin Psychol Rev. 2017 Nov;57:195-207
pubmed: 28781153
Drug Alcohol Depend. 2009 Jan 1;99(1-3):345-9
pubmed: 18819759
Annu Rev Psychol. 2016;67:23-50
pubmed: 26253543
Addict Biol. 2015 Jan;20(1):1-21
pubmed: 25403107
Cancer Chemother Pharmacol. 2002 Jul;50(1):65-70
pubmed: 12111114
J Neurosci Res. 2019 Apr 22;:
pubmed: 31006907
Addict Biol. 2018 Sep;23(5):1020-1031
pubmed: 28960802
JAMA. 2000 Aug 23-30;284(8):963-71
pubmed: 10944641
Genes Brain Behav. 2017 Jan;16(1):86-100
pubmed: 27657733
PLoS One. 2012;7(5):e36781
pubmed: 22574225
Neuropsychopharmacology. 2016 Nov;41(12):2795-2797
pubmed: 27312404
Biol Psychiatry. 2015 May 15;77(10):859-69
pubmed: 25433901
Neurosci Biobehav Rev. 2019 Nov;106:141-164
pubmed: 30243576
Am J Psychiatry. 2013 Sep;170(9):1020-31
pubmed: 23897038
JAMA. 2006 May 3;295(17):2003-17
pubmed: 16670409
Behav Brain Res. 2019 Apr 19;362:21-27
pubmed: 30630018
Annu Rev Pharmacol. 1969;9:483-502
pubmed: 4978013
Neuropsychopharmacology. 2014 Jan;39(1):220-9
pubmed: 24317307
Neuropsychopharmacology. 2008 Jan;33(1):56-72
pubmed: 17882236
J Neurosci. 2015 Jul 29;35(30):10750-61
pubmed: 26224858
Addict Biol. 2009 Jan;14(1):22-31
pubmed: 18855805
Nat Rev Neurosci. 2004 Jun;5(6):483-94
pubmed: 15152198
J Neurosci. 2013 Feb 13;33(7):2794-806
pubmed: 23407939
Brain Cogn. 2016 Oct;108:32-41
pubmed: 27429096
Annu Rev Clin Psychol. 2014;10:641-77
pubmed: 24679180
Nature. 2013 Apr 18;496(7445):359-62
pubmed: 23552889
Neuron. 2019 Apr 3;102(1):48-59
pubmed: 30946825
Biol Psychiatry. 2016 Oct 1;80(7):509-21
pubmed: 27450032
FASEB J. 2002 Jan;16(1):27-35
pubmed: 11772933
Alcohol Clin Exp Res. 2010 Sep 1;34(9):1565-73
pubmed: 20586757
Neurotox Res. 2008 Oct;14(2-3):249-62
pubmed: 19073430
Sci Rep. 2018 Jul 2;8(1):9908
pubmed: 29967489
Eur Neuropsychopharmacol. 2015 Aug;25(8):1167-77
pubmed: 26048580
Sci Transl Med. 2012 Jan 11;4(116):116ra6
pubmed: 22238334
Eur Neuropsychopharmacol. 2016 Dec;26(12):1950-1959
pubmed: 27842939
Front Psychiatry. 2013 May 06;4:31
pubmed: 23653607
Alcohol Alcohol. 2017 Nov 1;52(6):665-670
pubmed: 29036310
Addiction. 2017 Jun;112(6):1025-1035
pubmed: 28107772
J Psychiatry Neurosci. 2013 Jul;38(4):222-31
pubmed: 23182304
Addiction. 2018 Feb;113(2):220-237
pubmed: 28940866
Annu Rev Neurosci. 1991;14:421-51
pubmed: 1903243
Nat Rev Neurosci. 2011 Oct 20;12(11):652-69
pubmed: 22011681
Nat Commun. 2019 Sep 2;10(1):3934
pubmed: 31477694
Nat Neurosci. 2016 Dec;19(12):1553-1562
pubmed: 27749830
Addict Biol. 2016 Jan;21(1):3-22
pubmed: 26435524
Psychopharmacology (Berl). 2013 Oct;229(3):453-76
pubmed: 23685858
Eur Neuropsychopharmacol. 2018 Jul;28(7):795-806
pubmed: 29934090
Prog Neurobiol. 2018 Dec;171:15-31
pubmed: 30343034
Nat Rev Neurosci. 2009 Aug;10(8):561-72
pubmed: 19571793
Eur Neuropsychopharmacol. 2016 Sep;26(9):1419-1430
pubmed: 27397863
J Neurosci. 2016 Sep 7;36(36):9446-53
pubmed: 27605618
Br J Psychiatry. 2018 Jun;212(6):362-369
pubmed: 29716670
Nat Neurosci. 2011 Apr;14(4):420-2
pubmed: 21336273
Nat Rev Neurosci. 2016 Sep;17(9):592-9
pubmed: 27277868
Nat Rev Neurosci. 2009 Mar;10(3):224-34
pubmed: 19229241
Front Psychiatry. 2014 Oct 10;5:143
pubmed: 25346700
Lancet. 2010 Nov 6;376(9752):1558-65
pubmed: 21036393
Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):14134-9
pubmed: 8943073
Neurosci Biobehav Rev. 1991 Spring;15(1):35-43
pubmed: 2052196
Eur Neuropsychopharmacol. 2013 Aug;23(8):948-55
pubmed: 23141152
Pharmacol Ther. 2006 Sep;111(3):855-76
pubmed: 16545872
Trends Cogn Sci. 2011 Mar;15(3):132-9
pubmed: 21273114
Arch Gen Psychiatry. 1992 Nov;49(11):876-80
pubmed: 1345133
J Neurosci. 2014 Mar 26;34(13):4581-8
pubmed: 24672003
Curr Top Behav Neurosci. 2016;28:151-71
pubmed: 27240677
Psychopharmacology (Berl). 2015 Jul;232(13):2353-62
pubmed: 25697860
Transl Psychiatry. 2018 Sep 7;8(1):186
pubmed: 30194288
Lancet. 2018 Sep 22;392(10152):1015-1035
pubmed: 30146330
Am J Psychiatry. 2011 Mar;168(3):265-75
pubmed: 21247998
Neuropsychopharmacology. 2015 Mar 13;40(5):1053-63
pubmed: 25409596
Elife. 2016 Dec 10;5:
pubmed: 27938664
Lancet Psychiatry. 2018 Dec;5(12):987-1012
pubmed: 30392731
Psychopharmacology (Berl). 2013 Oct;229(3):387-413
pubmed: 23963530
Cold Spring Harb Symp Quant Biol. 2018;83:173-184
pubmed: 31097615
Mol Psychiatry. 2011 Aug;16(8):809-17
pubmed: 20479755
Neuropharmacology. 2014 Jan;76 Pt B:518-27
pubmed: 23806805
Trends Cogn Sci. 2017 Jul;21(7):531-545
pubmed: 28495311
Nat Rev Neurosci. 2011 Oct 12;12(11):623-37
pubmed: 21989194
Lancet. 2009 Jun 27;373(9682):2234-46
pubmed: 19560605
J Addict Med. 2013 Jul-Aug;7(4):277-86
pubmed: 23728065
Neuropsychopharmacology. 2005 Jan;30(1):205-11
pubmed: 15525998
Addiction. 2011 Mar;106(3):657-69
pubmed: 21077975
Neuropsychopharmacology. 2017 Feb;42(3):606-614
pubmed: 27510425
Acta Psychiatr Scand. 2018 Sep;138(3):232-242
pubmed: 29888478
Am J Psychiatry. 2002 Oct;159(10):1642-52
pubmed: 12359667
Neuropsychopharmacology. 2014 Mar;39(4):783-91
pubmed: 24081303
Alcohol Clin Exp Res. 2010 Nov;34(11):1849-57
pubmed: 20662805
Nat Neurosci. 2005 Nov;8(11):1481-9
pubmed: 16251991
Neurosci Biobehav Rev. 2019 Nov;106:202-216
pubmed: 30343823
Addict Biol. 2015 Nov;20(6):1012-21
pubmed: 25146961
Alcohol. 2019 Feb;74:73-82
pubmed: 30424979
Mol Psychiatry. 2017 Dec;22(12):1746-1758
pubmed: 27573876
Pharmacogenomics J. 2013 Jun;13(3):286-96
pubmed: 22614244
Nature. 2015 Jan 15;517(7534):284-92
pubmed: 25592533
Addict Biol. 2020 May;25(3):e12744
pubmed: 30907042
Nat Neurosci. 2009 Aug;12(8):1069-73
pubmed: 19620976
Neuroreport. 1993 Dec 13;5(3):277-80
pubmed: 8298090
Psychiatr Serv. 2010 Apr;61(4):392-8
pubmed: 20360279
Arch Gen Psychiatry. 1992 Nov;49(11):881-7
pubmed: 1444726
Neuron. 2015 May 6;86(3):646-64
pubmed: 25950633
Alcohol Clin Exp Res. 2014 Jun;38(6):1481-8
pubmed: 24796492
JAMA. 2014 May 14;311(18):1889-900
pubmed: 24825644
Psychopharmacology (Berl). 1999 Oct;146(4):373-90
pubmed: 10550488
Behav Brain Res. 2003 Nov 30;146(1-2):3-17
pubmed: 14643455
Biol Psychiatry. 2008 Jan 15;63(2):139-45
pubmed: 17585886
J Stud Alcohol Drugs. 2011 Nov;72(6):943-53
pubmed: 22051208
Psychopharmacology (Berl). 2009 Aug;205(3):389-97
pubmed: 19418040
Biol Psychiatry. 2017 Dec 1;82(11):781-793
pubmed: 28648649
J Neurosci. 2016 Jun 22;36(25):6691-703
pubmed: 27335401
Neuropsychopharmacology. 2014 Mar;39(4):907-18
pubmed: 24136292
Addict Biol. 2010 Apr;15(2):169-84
pubmed: 20148778
JAMA. 2007 Oct 10;298(14):1641-51
pubmed: 17925516
Am J Psychiatry. 2014 Apr;171(4):445-52
pubmed: 24525690
Lancet. 2007 Dec 8;370(9603):1915-22
pubmed: 18068515
Nat Rev Neurosci. 2013 Nov;14(11):743-54
pubmed: 24088811
Arch Gen Psychiatry. 2007 Jul;64(7):830-42
pubmed: 17606817
J Neurosci. 2018 Apr 4;38(14):3507-3519
pubmed: 29483279
Neuropsychopharmacology. 2017 Dec;42(13):2553-2566
pubmed: 28664928
Life Sci. 1980 Mar 3;26(9):679-88
pubmed: 6767889
Nat Neurosci. 2013 Aug;16(8):1111-7
pubmed: 23792945
Annu Rev Psychol. 2008;59:29-53
pubmed: 18154498
Nat Med. 2005 Jan;11(1):35-42
pubmed: 15608650
Addict Biol. 2018 Jul;23(4):961-968
pubmed: 30043407
Arch Gen Psychiatry. 2010 Oct;67(10):1069-77
pubmed: 20921123
Trends Neurosci. 2007 Aug;30(8):399-406
pubmed: 17629579
Science. 1997 Oct 3;278(5335):45-7
pubmed: 9311924
Brain Res. 2015 Dec 2;1628(Pt A):157-73
pubmed: 25446457
Trends Mol Med. 2018 Feb;24(2):121-128
pubmed: 29307501
Alcohol Clin Exp Res. 2011 Oct;35(10):1749-58
pubmed: 21615426
Addict Biol. 2012 May;17(3):513-27
pubmed: 22458728
Brain Res. 2004 Mar 12;1000(1-2):192-4
pubmed: 15053967
Biol Psychiatry. 2013 Apr 15;73(8):706-13
pubmed: 23237314
Lancet Psychiatry. 2015 Jan;2(1):105-10
pubmed: 26359616
eNeuro. 2018 Oct 25;5(5):
pubmed: 30406193
Physiol Rev. 2009 Apr;89(2):649-705
pubmed: 19342616
Science. 1981 Jan 30;211(4481):453-8
pubmed: 7455683
JAMA Psychiatry. 2015 Aug;72(8):757-66
pubmed: 26039070

Auteurs

Markus Heilig (M)

Center for Social and Affective Neuroscience, Department of Clinical and Experimental Medicine, Linköping University, S-581 83, Linköping, Sweden. markus.heilig@liu.se.

Eric Augier (E)

Center for Social and Affective Neuroscience, Department of Clinical and Experimental Medicine, Linköping University, S-581 83, Linköping, Sweden.

Simone Pfarr (S)

Institute of Psychopharmacology, Central Institute of Mental Health (CIMH), J 5, 68159, Mannheim, Germany.

Wolfgang H Sommer (WH)

Institute of Psychopharmacology, Central Institute of Mental Health (CIMH), J 5, 68159, Mannheim, Germany. wolfgang.sommer@zi-mannheim.de.
Department of Addiction Medicine, Central Institute of Mental Health (CIMH), J 5, 68159, Mannheim, Germany. wolfgang.sommer@zi-mannheim.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH